Bhatt Nailesh 4
4 · Sonnet BioTherapeutics Holdings, Inc. · Filed May 18, 2023
Insider Transaction Report
Form 4
Bhatt Nailesh
Director
Transactions
- Purchase
Common Stock
2023-05-17$0.23/sh+25,000$5,800→ 30,733 total
Footnotes (1)
- [F1]Includes unvested RSUs.